These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23925693)

  • 1. The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.
    Tornese G; Iafusco D; Monasta L; Agnoletto C; Tisato V; Ventura A; Zauli G; Secchiero P
    Acta Diabetol; 2014 Apr; 51(2):239-46. PubMed ID: 23925693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients.
    Xiang G; Zhang J; Ling Y; Zhao L
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):228-34. PubMed ID: 23931066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
    Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
    Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
    Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with type 1 diabetes of early age at onset - immune and metabolic phenotypes.
    Sales Luis M; Alcafache M; Ferreira S; Fitas AL; Simões Pereira J; Caramalho Í; Lopes L; Limbert C
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):935-941. PubMed ID: 31280235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.
    Cheung SS; Metzger DL; Wang X; Huang J; Tai J; Tingle AJ; Ou D
    Pancreas; 2005 Mar; 30(2):105-14. PubMed ID: 15714132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
    Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease.
    Celeghini C; Not T; Norcio A; Monasta L; Secchiero P
    Exp Ther Med; 2014 Dec; 8(6):1906-1908. PubMed ID: 25371753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.
    Matejko B; Cyganek K; Katra B; Galicka-Latala D; Grzanka M; Malecki MT; Klupa T
    Rev Diabet Stud; 2011; 8(2):254-8. PubMed ID: 22189548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis.
    Cengiz E; Connor CG; Ruedy KJ; Beck RW; Kollman C; Klingensmith GJ; Tamborlane WV; Lee JM; Haller MJ;
    Pediatr Diabetes; 2014 Jun; 15(4):287-93. PubMed ID: 23944865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.
    Blasetti A; Di Giulio C; Tumini S; Provenzano M; Rapino D; Comegna L; Prezioso G; Chiuri R; Franchini S; Chiarelli F; Stuppia L
    Pharmacogenomics J; 2017 Mar; 17(2):186-191. PubMed ID: 26902538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China.
    Yang L; Yang G; Li X
    BMC Endocr Disord; 2021 Jun; 21(1):131. PubMed ID: 34176476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus.
    Tornese G; Tisato V; Monasta L; Vecchi Brumatti L; Zauli G; Secchiero P
    Acta Diabetol; 2015 Oct; 52(5):1003-6. PubMed ID: 25863780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood].
    Młynarski W; Zmysłowska A; Kubryn I; Perenc M; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):23-8. PubMed ID: 12831634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies.
    Winkler C; Schober E; Ziegler AG; Holl RW
    Pediatr Diabetes; 2012 Jun; 13(4):308-13. PubMed ID: 22060727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.
    Mazarello Paes V; Barrett JK; Dunger DB; Gevers EF; Taylor-Robinson DC; Viner RM; Stephenson TJ
    Pediatr Diabetes; 2020 Mar; 21(2):288-299. PubMed ID: 31782879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.